An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Additionally, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Material Elimination
Based on the social media company, the platform has removed problematic content and banned related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform safe and investing in enhancing compliance measures.
Online Marketplace Operations
Investigations also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, filled with photos of slimming results, glowing reviews and detailed guides for mixing or administering at home.
Within moments of entering one group, a seller shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Product Information and Pricing
Within these groups, messages show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually priced at £160 for 20mg. When asked how long a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service said it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering substances they can’t verify. Even if the research behind this drug is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the surge in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to potentially serious health risks”.
